111264-84-7 Usage
Type
Steroid hormone
It is a hormone that is similar in structure to natural corticosteroids produced by the body.
Medicinal use
Anti-inflammatory and immunosuppressant
The drug is used to reduce inflammation and suppress the body's immune response.
Common treatments
Asthma, eczema, arthritis, and allergic reactions
Mechanism of action
Reducing the body's natural immune response and decreasing inflammation
The chemical works by modulating the immune system and reducing inflammation to provide relief.
Side effects
Weight gain, increased blood sugar levels, and an increased risk of infection
Various side effects may occur, and the drug should be used with caution.
Supervision
Should only be used under the supervision of a healthcare professional
A medical professional should monitor the use of this drug to ensure its safety and effectiveness.
Check Digit Verification of cas no
The CAS Registry Mumber 111264-84-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,2,6 and 4 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 111264-84:
(8*1)+(7*1)+(6*1)+(5*2)+(4*6)+(3*4)+(2*8)+(1*4)=87
87 % 10 = 7
So 111264-84-7 is a valid CAS Registry Number.
111264-84-7Relevant articles and documents
Radiolytic degradation scheme for 60Co-irradiated corticosteroids
Kane,Tsuji
, p. 30 - 35 (1983)
The cobalt 60 radiolytic degradation products have been identified in the following corticosteroids: cortisone, cortisone acetate, hydrocortisone, hydrocortisone acetate, hydrocortisone sodium succinate, isoflupredone acetate, methylprednisolone, methylprednisolone acetate, prednisolone, prednisolone acetate, and prednisone. Two major types of degradation processes have been identified: loss of the corticoid side chain the D-ring to produce the C-17 ketone and conversion of the C-11 alcohol, if present, to the C-11 ketone. Minor degradation products derived from other changes affecting the side chain are also identified in several corticosteroids. These compounds are frequently associated in corticosteroids as process impurities or degradation compounds. No new radiolytic compounds unique to 60Co-irradiation have been found. The majority of corticosteroids have been shown to be stable to 60Co-irradiation. The rates of radiolytic degradation ranged from 0.2 to 1.4%/Mrad.
